Suez Canal University
Ismailia, Egypt
NCT Number: NCT06619535
The goal of this retrospective study is to explore the association between sepsis and morality among the elderly cancer patients. Data were extracted from the Surveillance, Epidemiology and End Results( SEER) database using SEER*stat software. The study included patients aged 65 years or more who were diagnosed with cancer from 2000 to 2021. The extracted data included age, race, marital status, sex, stage, surgery, chemotherapy and radiotherapy. Multiple primary session was used to calculate the standardized Mortality ratio (SMR) as Observed/Expected with excess risk/10,000 and significance was achieved at 0.05.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Ismailia, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from Jan, 2000 till Dec, 2021
Patients were followed up from the time of diagnosis and the risk was assessed across different time intervals: 1 year, 5 years and +10 years after cancer diagnosis from 2000 to 2021
asmaa salama ibrahim
Other
Sepsis As a Cause of Death Among Elderly Cancer Patients: an Updated SEER Database Analysis 2000-2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03767517
Brain Diseases, Cancer
Alexander City, Alabama, United States
View Trial DetailsNCT04916223
Blood-Borne Infections, Brain Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT00930085
Cancer, Infections
Marseille, France
View Trial DetailsNCT06541600
Infections, Inflammation
Wuhan, Hubei, China
View Trial Details